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A 62-year-old man presented with sudden loss of vision in conjunction 
with distorted vision in his right eye.  He denied seeing flashing lights or 
new floaters or having any previous trauma.  His visual acuity was 6/24 in 
his right eye and 6/6 in his left eye.
The fundus photograph is compatible with the patient having which of 
the following?
1. Branch retinal vein occlusion 
2. Branch retinal artery occlusion 
3. Diabetic retinopathy 
4. Cytomegalovirus retinitis
Please find the answer on page 36.
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1.  Branch retinal vein occlusion
Sudden painless loss of vision is typically associated with retinal conditions.  Common 
causes of painless loss of vision include retinal vein occlusion, retinal artery occlusion, retinal 
detachment, and vitreous hemorrhage.
Retinal vein occlusion can be clinically classified as branch hemi-, or central, depending on 
where the retinal hemorrhage is located.  in central retinal vein occlusion, the hemorrhage is 
located in all four quadrants.  in hemi-retinal vein occlusion, the hemorrhage is located in only 
half of the retina.  in branch retinal vein occlusion, the hemorrhage is located in a specific area 
drained by a specific retinal venule.
Retinal vein occlusion is thought to be related to the common adventitial sheath that is 
shared by a retinal vein and artery.1  in almost all (99%) patients in this condition, the artery is 
located anterior to the vein.2  The high differential pressure that exists between the artery and 
vein is though to cause the vein to collapse as it is compressed by the artery on one side and the 
retina on the other.  This collapse causes venous return turbulence eddies that in turn lead to 
formation of an intravenous thrombosis at the arterial venous crossing.1  Although this is the 
typical pathogenic mechanism for formation of retinal vein occlusion, other factors, such as 
hypercoagulable states, diabetes mellitus, glaucoma, and prothrombotic conditions, could be 
implicated also.1,3
Patients with retinal vein occlusion have a variable prognosis for improvement in vision.4,5 
Poor vision can be associated with macular hemorrhage, macular edema that might complicate 
branch retinal vein occlusion, or vitreous hemorrhage secondary to posterior segment 
neovascularization.1  
The Branch Retinal Vein Study, a multicentre, randomized clinical trial sponsored by the 
United States National institutes of Health, demonstrated that laser photocoagulation was 
beneficial in two situations: when the occlusion was complicated by macular edema and 
a patient’s visual acuity was less than 6/12,4 and when the occlusion was complicated by 
formation of new blood vessels in the retina.5 More recently intravitreal injection with anti-
VEGF compounds and steroids have been proven to increase the risk of significant visual 
improvement.6,7,8
MANAgEMENt
The patient was referred to an ophthalmologist on an urgent basis.  Dilated funduscopic 
examination demonstrated mild hypertensive retinopathy in the contralateral eye and a branch 
retinal vein occlusion in the affected eye.  The patient was also noted to have substantial 
macular edema.  He was referred to a retinal specialist, and the diagnosis of branch retinal vein 
occlusion with macular edema was confirmed.  The patient also had a systemic workup that 
included blood pressure measurement; a fasting blood sugar test; prothrombin time and partial 
thromboplastin time test; and blood test for abnormalities in proteins C and S, antithrombin iii, 
and a screen for a mutation in factor V.
The patient was offered intravitreal injection with an anti-VEGF compound. After a series of 
injections the vision had improved to 6/9.
rECoMMENdAtIoN
Patients with sudden loss of vision should be evaluated by an ophthalmologist on an urgent 
basis.  Patients with branch retinal vein occlusion should have a thorough systemic evaluation 
because many of these patients have some systemic abnormality.  Patients with branch retinal 
vein occlusion can develop macular edema and retinal neovascularization.  These complications 
can be treated with intravitreal injection with an anti-VEGF compound, intraocular steroids or 
laser photocoagulation.
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Learn more about hypertension and the eye, online at Optocase.com
To learn more about how hypertension can present in the back of the eye, please consider 
taking the COPE-approved case study on Hypertensive Retinopathy online at  www.optocase.com 
(worth two hours of COPE credit).  The CAO has arranged that members can take the case for 
free until January 31, 2015 - use coupon code HRFREE on the Cases page (you will need to 
register for free first).
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